A group of healthcare professionals at Gift of Life Institute is conducting a research study to determine the effects of Neoral® (cyclosporine, USP) MODIFIED on pregnancy in women who have psoriasis or rheumatoid arthritis. Our purpose is to enroll all women with either psoriasis or rheumatoid arthritis who are pregnant and are taking Neoral® (cyclosporine, USP) MODIFIED. One of our goals is to gather information to determine the safety of using Neoral® (cyclosporine, USP) MODIFIED during pregnancy in this patient population.
If you would like to enroll in the registry, you are encouraged to contact the registry as early in the pregnancy as possible. When you enroll in the registry, the study coordinator will call you for an initial 30 minute interview during your pregnancy, and again for a 30 minute follow up interview after your pregnancy. Patient confidentiality is strictly maintained.
If you have questions or would like more information about the Neoral® Pregnancy Registry for Psoriasis and Rheumatoid Arthritis, please contact us at 1-888-522-5581 or through the form below.
Vincent T. Armenti, MD, PhD
Michael J. Moritz, MD
Lisa A. Coscia, RN, BSN, CCTC
Carolyn H. McGrory, MS, RN